|
|
||||||||
1From the National Eye Institute, the 3National Human Genome Research Institute, and the 4National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland; 5Howard Hughes Medical Institute, Bar Harbor, Maine; 6The Jackson Laboratory, Bar Harbor, Maine; and the 7Comparative Genetics Program, Texas A & M University, College Station, Texas.
| Abstract |
|---|
|
|
|---|
METHODS. Chocolate mice (cht, Rab38cht/cht) and control heterozygous (Rab38cht/+) and wild-type mice were examined clinically, histologically, ultrastructurally, and electrophysiologically. Mice homozygous for both the Rab38cht and the Tyrp1b alleles were similarly examined.
RESULTS. Rab38cht/cht mice showed variable peripheral iris transillumination defects at 2 months of age. Patches of RPE hypopigmentation were noted clinically in 57% of Rab38cht/cht eyes and 6% of Rab38cht/+ eyes. Rab38cht/cht mice exhibited thinning of the iris and RPE and larger b-wave amplitudes in the scotopic range when compared with the control animals. Compared with wild-type mice, Rab38cht/cht melanosomes were smaller and there were fewer in neuroectodermally derived retinal pigment epithelium; in neural crest-derived choroid melanocytes, they were smaller in size only. Mutation of both Rab38 and Tyrp1 produced mice with ocular and coat color pigment dilution greater than that seen with either mutation alone. Comprehensive clinical and pathologic analyses showed no other organ system or blood defects in Rab38cht/cht mice.
CONCLUSIONS. Rab38cht/cht mice show ocular characteristics reminiscent of human oculocutaneous albinism, as well as iris and RPE thinning. The synergistic effects of the Rab38cht and Tyrp1b alleles suggest that TYRP1 is not the only target of RAB38 trafficking. This mouse line provides a useful model for studying melanosome biology and its role in human ocular diseases.
Melanin production occurs in specialized organelles within pigment cells called melanosomes. The melanin synthetic enzymes (including tyrosinase, tyrosinase-related protein 1 (TYRP1), and dopachrome tautomerase) must be trafficked within the melanocyte to the melanosome to achieve proper melanin production. Variations in the coat color of mouse mutants can result from the absence of pigment cells (white spots), defects in melanogenic enzymes, and aberrant trafficking of melanogenic proteins to the melanosome (color alterations or dilution).
Genes mutated in mice with coat color variations have often been associated with human pigmentary anomalies with similar phenotypes. These include pigmentary glaucoma,2 3 oculocutaneous and X-linked ocular albinism,4 5 6 7 Hermansky-Pudlak syndrome (HPS),8 and Chediak-Higashi syndrome. HPS is an autosomal recessive disease characterized by variable oculocutaneous albinism (including foveal hypoplasia, nystagmus, and iris transillumination defects), absent platelet-dense bodies (leading to prolonged bleeding times), and sporadic lung fibrosis.9 10 Genes for 16 hypopigmented mouse mutants with platelet-mediated bleeding defects have been cloned, and mutations in the human orthologous genes, most of which are involved in organelle trafficking, were subsequently found in humans with HPS.11 12 13
Similarly, Tyrp1b/b mice carry a mutation in a melanin synthetic enzyme and exhibit a brown coat on a wild-type black strain background. Patients with oculocutaneous albinism type 3 (OCA3) have homozygous TYRP1 mutations,6 14 which result in moderate hypopigmentation. Of course, there can be human and mouse phenotype differences for disruption of the same gene. For example, mutation of Tyrp1 in both humans and mice results in hypopigmentation and iris transillumination. However, DBA/2J mice homozygous for the Tyrp1b allele develop age-dependent iris stromal atrophy, elevated intraocular pressure, and pigmentary glaucoma, which has not been observed in humans with TYRP1 mutations.2 3 This difference in known human and mouse phenotypes may be due to the nature of the mutation and whether or not the mutant TYRP1 protein can still stabilize tyrosinase. Because the mouse iris atrophy phenotype is dependent on pigment production and known human mutations induce ocular albinism, it has been suggested that the human mutations are self-rescuing with respect to iris atrophy.2 3
The chocolate (Rab38cht/cht) mouse mutant arose spontaneously on the C57BL/6J black background as a dark brown coat color variant. A G19V point mutation in a highly conserved amino acid of Rab38 is responsible for the chocolate phenotype.15 16 Rab38cht/cht mice have normal blood clotting times. In addition to the chocolate mouse, RAB38 is altered in a rat coat color mutant called Ruby (red-eyed dilution, R) which has been proposed as an animal model for HPS.17 Ruby rats have hypopigmented eyes and coat and a bleeding diathesis. The Ruby Rab38 translation-initiation codon has a missense mutation that is predicted to stop translation at the first codon and RAB38 protein is not detected. However, unlike in patients with HPS, platelet-dense granules are present with normal appearance and numbers in Fawn-hooded hypertensive rats, which also carry a first codon missense mutation in Rab38 and have a Ruby phenotype of hypopigmentation and platelet storage pool defect.18 19
Rabs are small GTP-binding proteins involved in vesicular transport, motility, and fusion in the secretory and endocytic pathways of cells.20 21 The precise function of RAB38 remains unknown, although it appears to be important in melanogenesis and necessary for proper targeting of TYRP1 protein in melanosomes.16 Given the role of Rab proteins in trafficking and the association of alterations of Rab38 with coat color variants, Rab38cht/cht mice may be a model for an HPS-like syndrome, or—like Tyrp1b/b mice—may develop an age-dependent form of pigmentary glaucoma or may display ocular albinism similar to OCA3.
In this study, the ocular phenotype in Rab38cht/cht, Rab38cht/+, and wild-type mice was assessed by using clinical examination, histopathology, electrophysiology, and ultrastructural techniques. Because preliminary evidence suggested that RAB38 is important in TYRP1 targeting, we examined mice homozygous for both the Rab38cht and Tyrp1b alleles. To investigate whether alterations in RAB38 are associated with human disease, RAB38 was sequenced in a small group of human subjects with ocular and/or systemic pigmentary abnormalities.
| Materials and Methods |
|---|
|
|
|---|
Clinical examination of the anterior segment was performed on gently restrained, awake mice with a slit lamp (BQ; Haag-Streit, Mason, OH) and an indirect ophthalmoscope (Keeler, Windsor, Berkshire, UK) with a 90-D condensing lens (Volk, Mentor, OH). The mice were euthanatized with carbon dioxide according to institutional guidelines. "Young" mice were defined as 2 to 3 months of age; "aged" mice were defined as older than 1 year. The fundi were also examined.
For body organ and blood system analysis, three male and three female 5-month-old Rab38cht/cht mice were compared with six, age- and sex-matched wild-type control mice. We analyzed differences in organ morphology, serum chemistries, hematocrit, and neutrophil and platelet counts between Rab38cht/cht and wild-type mice. Age-related coat color changes were observed by visual comparison of subgroups of mice.
These studies conformed to the principles for laboratory animal research outlined by the Animal Welfare Act (National Institutes of Health/Department of Health and Human Services) and the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and were approved by the Institutional Animal Care and Use Committee.
Histopathology, Electron Microscopy, and Melanosome Image Analysis
For light microscopy, mouse eyes were enucleated and fixed in a phosphate-buffered paraformaldehyde–glutaraldehyde mixture, according to published protocols.22 Hematoxylin and eosin–stained methacrylate-fixed sections from the pupillary–optic nerve axis were used for histopathology.
For electron microscopy, mouse eyes were dissected and fixed in 4% glutaraldehyde in 0.15% phosphate buffer for 1 hour at room temperature and then transferred to 4% paraformaldehyde for overnight fixation at 4°C. Ocular tissue samples were processed through ascending alcohols, propylene oxide, and a 50:50 mixture of propylene oxide and Ladd LX112 epoxy resin. They were then infiltrated with 100% LX112 and embedded in fresh resin. Samples were cut in a cryotome (Ultracut R; Leica), stained with uranyl acetate and lead citrate, and examined by electron microscope (JEM 1010; JEOL, Tokyo, Japan).
The density and cross-sectional areas of melanosomes in the RPE and choroid of Rab38cht/cht, Rab38cht/+, and Rab38+/+ mice were measured from randomly selected transmission electron microscopy images at 5000x magnification (AxioVision LE, ver. 4.5; Carl Zeiss Meditec, Dublin, CA). Care was taken to image comparable areas of the posterior pole between different groups of mice. At least three independent images were analyzed for each group. RPE areas analyzed per sample were between 75 and 115 µm2.
Electrophysiology
Electroretinograms (ERGs) were recorded in 2- to 3-month-old homozygous Rab38cht/cht, heterozygous Rab38cht/+, and wild-type (C57BL/6 Rab38+/+) mice. They were dark-adapted for 12 hours before intraperitoneal anesthesia with ketamine (80 mg/kg) and xylazine (4 mg/kg). After instillation of 1% proparacaine anesthetic, the pupils were dilated with topical 0.5% tropicamide and 0.5% phenylephrine HCl. Body temperature was maintained near 38°C with a heating pad. ERGs were recorded simultaneously from both eyes, with gold wire loops placed on the cornea with a drop of methylcellulose. Gold wires were placed on the sclera at the limbus as the differential electrodes, and the ground wire was attached to the left paw.
Scotopic ERG responses were elicited in the dark-adapted state with single xenon photostrobe flashes (PS33 Photic Stimulator; Grass-Telefactor; West Warwick, RI) delivered in a Ganzfeld light-integrating sphere, with interstimulus intervals of 3 to 60 seconds depending on stimulus intensity. The stimulus intensity range of –6.9 to +0.6 log cd-s/m2 was obtained with neutral density (ND) filters (Wratten; Eastman Kodak, Rochester, NY). Responses in a frequency range of 0.1 to 1000 Hz (3-dB cutoff) were amplified 5000 times with a 60-Hz line frequency notch filter (CP511 AC amplifier; Grass-Telefactor). Photopic responses were elicited in a light-adapted state on a rod-suppressing white background of 34 cd/m2, with single flashes at 2-second interstimulus intervals. Up to 20 responses were averaged at all intensities tested. The a-waves were measured from the prestimulus baseline to the initial trough. The b-waves were measured either from the baseline or from the a-wave trough when present. Implicit times were measured from flash onset to the a- and b-wave maximum.
Intensity–response amplitude data were displayed conventionally on log–log coordinates and log-linear coordinates. Response profiles were compared across intensity range by mixed ANOVA (PROC MIXED in SAS for Windows; ver. 9.0.2; SAS Institute, Inc., Cary, NC).
RAB38 Antibody Production and Protein Detection
Polyclonal affinity-purified rabbit anti-mouse Rab38 was prepared by Bio-Synthesis, Inc. (Lewisville, TX). Rab38 antigen sequence LESIEPDIVKPHLTS, position 188-203, was chosen to minimize any homology with other Rab proteins, using multisequence Rab alignment.23
Western blot analysis was performed on immortalized melanocyte cell lines: control melan-Ink4a-1, which produces normal black pigment, and melan-Ink4a-cht5, which is homozygous for Rab38cht/cht mutation. Decreasing amounts of both protein preparations were loaded on two nondenatured, precast, 4% to 20% Tris-glycine gels (Invitrogen, Carlsbad, CA) and transferred to polyvinylidene difluoride (PVDF) membranes (Invitrogen). The membranes were incubated with 1:100 dilution anti-Rab38 antibody or 1:100 dilution anti-Rab38 and 1:1000 dilution anti-tubulin antibodies (MP Biomedicals, Inc., Aurora, IL). A peroxidase-linked secondary antibody was added (GE Healthcare, Piscataway, NJ) and detected with chemiluminescence (ECL kit; GE Healthcare).
Human Mutation Analysis
Research subjects with Hermansky-Pudlak syndrome or with a Hermansky-Pudlak–like syndrome (i.e., patients with oculocutaneous albinism and indications of a bleeding defect, but with normal-appearing platelet-dense bodies) and patients with oculocutaneous albinism or pigmentary glaucoma consented to venipuncture and research-based DNA analysis. The subjects' genomic DNA was PCR amplified exon by exon (primers available on request), with standard techniques,24 and directly sequenced. Automated sequencing was performed (CEQ 2000 sequencer, with CEQ Dye-Terminator Cycle Sequencing kit; Beckman Coulter, Fullerton, CA) according to the manufacturer's protocols. The deposited GenBank sequence (NM_022337) was used as a reference for identifying polymorphisms (http://www.ncbi.nlm.nih.gov/Genbank; provided in the public domain by the National Center for Biotechnology Information, Bethesda, MD).
All human subject research was conducted with the approval of local Institutional Review Boards and was in compliance with the Declaration of Helsinki.
| Results |
|---|
|
|
|---|
|
Although measurement of intraocular pressure was not performed, there was no clinical or histologic evidence of glaucoma in Rab38cht/cht mice greater than 1 year of age, as would be observed in Tyrp1b/b mice. Specifically, there was no deepening of the anterior chamber, ectasia of the cornea, or cupping of the optic nerve on clinical examination, nor was there any evidence of significant ganglion cell loss or optic nerve atrophy on histologic sections (data not shown).
We performed histopathology on Rab38cht/cht and Rab38cht/+ mice in both young and old cohorts of mice. The irides of young Rab38cht/cht mice showed thinning and hypopigmentation compared with age-matched Rab38cht/+ control mice (Fig. 2) . Thinning was most pronounced peripherally and was variable. Different severities of thinning were often observed in the same eye when different sections of the iris were sampled. Examination of the irides of the aged cohort of Rab38cht/cht mice showed no qualitative difference from those in the young cohort, consistent with our clinical observation that there was no atrophic component to this iris thinning (data not shown).
|
|
|
|
|
Levels of RAB38 Protein.
To determine the amount of RAB38 protein in wild-type and Rab38cht/cht cells, we developed an anti-RAB38 antibody. On Western blot, anti-RAB38 antibody recognizes a single, correctly sized protein band in a mouse melanocyte cell line (Fig. 6) . The mouse skin melanocyte cell lines we used are homozygous for the Ink4a null mutation, to allow for rapid immortalizing, and are from the same inbred mouse background (C57BL/6). Therefore, melan-Ink4a-1 cells and melan-Ink4a-cht5 cells should differ only at the Rab38 locus. Melan-Ink4a-cht5 cells homozygous for the Rab38cht allele showed much-reduced RAB38 protein expression on Western blot analysis.
|
|
1 month old) Rab38cht/cht mice, unlike the dark coats of Rab38cht/+and wild-type littermates. At approximately 3 months of age, the Rab38cht/cht coat color had darkened, but remained distinguishable from the black coats of the Rab38cht/+ and wild-type littermates (Fig. 8) .
|
|
|
| Discussion |
|---|
|
|
|---|
We examined the anterior segments, RPE, and other aspects of the eyes of Rab38cht/cht mice. The results showed that Rab38cht/cht mice display iris and RPE thinning and focal depigmentation as well as ocular phenotypes similar to those of human OCA. For example, electroretinography performed on young Rab38cht/cht mice is reminiscent of findings in some humans with albinism. Krill and Lee25 describe supranormal ERG responses under scotopic conditions in patients with oculocutaneous or ocular albinism. Photopic and flicker fusion responses were normal, however, and carriers of X-linked albinism were not significantly different from those in control subjects. They also observe that the scotopic changes in the albino ERG tend to normalize with age, perhaps due to increased pigmentation over time. Because our measurements were conducted in the mice at 3 months of age, they are most likely to model the findings in younger patients with albinism. Krill and Lee postulate that this supranormal ERG is the result of increased internal reflection of light within the eye from reduced pigmentation. This response, however, has not been observed in all patients with albinism.26 27 28
The ocular pigment dilution in Rab38cht/cht mice is most likely due to the presence of fewer and smaller melanosomes in the RPE and/or smaller melanosomes in the choroid. Our analysis suggests that the role of Rab38 is more pronounced in neuroectodermally derived structures, such as the RPE, than in NC-derived tissues, such as the choroidal melanocytes. Although the precise reason for this difference is unclear, recent experiments by Wasmeier et al.29 have shown that Rab32 and Rab38 may have redundant roles in melanogenesis. A tissue-specific difference in the effect of the Rab38 mutation could therefore be related to a difference in Rab32 expression. Although we did not quantitate melanosome size and number in older animals, we suspect that the age-related increase in pigmentation observed in these mice is related to compensatory changes in melanocytes with time. Similar increasing pigmentation has been noted clinically in some patients with OCA.30
In the Tyrp1b/b mouse, the number of RPE and choroidal melanosomes is decreased,31 and the Tyrp1b/b melanosomes are smaller and rounder than in the wild-type mouse.32 Other data suggest the Rab38 is involved in appropriate targeting of TYRP1 within melanocytes,16 and the Rab38cht/cht mouse brown coat and eye color on a black strain background resembled the Tyrp1b/b phenotype. Murine Tyrp1 functions enzymatically in the synthesis of eumelanin (black melanin), and melanin formed in Tyrp1b/b mutant is brown.33 34 35 36 Additional functions of Tyrp1 include stabilization of the melanin-synthesizing enzyme, tyrosinase, in melanosomes, and maintenance of melanosomal structure.
To investigate the relationship of Rab38 and Tyrp1 in vivo, we created mice homozygous for the Rab38cht allele and the Tyrp1b allele. The double-mutant mice showed a striking loss of pigmentation that was qualitatively greater than the sum of hypopigmentation observed in Rab38cht/cht Tyrp1+/+ and Rab38+/+Tyrp1b/b mice. This finding suggests that there is not a simple linear relationship between RAB38 function and TYRP1 function. If the sole role of RAB38 was to target TYRP1 to melanosomes properly, we would expect that disruption of RAB38 function would have little effect on the Tyrp1b/b phenotype, as both proteins would function in the same "linear" pathway to produce pigment. Our observations that the double mutants were significantly hypopigmented implies that TYRP1 is not the only protein involved in RAB38-mediated pigment, particularly in the neuroectodermally derived layers of the eye. The double mutants may have such a dramatic phenotype because of misrouting of proteins other than TYRP1 to the melanosomes.
Tyrp1b/b mice on a DBA/2J background develop iris stromal atrophy and pigmentary glaucoma with age.2 3 Iris transillumination, which is observed in Rab38cht/cht mice, can be seen in iris atrophy as well as in hypopigmentation. To address this, we examined the irides of an aged cohort of Rab38cht/cht mice and found no qualitative difference from a young cohort. There was no evidence in young or aged Rab38cht/cht of significant iris atrophy, pigment dispersion, or glaucoma. Therefore, the iris transillumination in Rab38cht/cht mice was more likely due to hypopigmentation and/or hypoplasia of the iris rather than to iris atrophy. The possibility remains that a Rab38 mutation could cause a pigmentary glaucoma phenotype on other mouse genetic backgrounds and/or could act as a modifier allele of this disease.
In one patient with pigmentary glaucoma, the Rab38 sequence showed a heterozygous c.C583A change, which is predicted to cause a p.P195T change. Whether this change is disease-related is unclear. This proline is well-conserved across mammalian species (mouse, rat, chimpanzee, cow, and dog). Although a proline-to-threonine change is likely to be significant, the fact that Rab38cht/+ mice appeared identical with wild-type mice and that Rab38cht/cht mice did not develop pigmentary glaucoma argues against heterozygous changes having primary pathologic consequences in humans.
Two lines of evidence suggest that Rab38 mutation may cause human Hermansky-Pudlak syndrome. First, the rat HPS model Ruby (red-eyed dilution, R) hypopigmentation and bleeding phenotype is caused by an Rab38 mutation. No RAB38 protein is produced in the Ruby rat.17 In addition, Rab38, like other Rabs, is probably involved in vesicular trafficking, and several known HPS genes are intracellular vesicle trafficking proteins.9 16
We did not observe any blood or organ system defects in the Rab38cht/cht mice. Neutrophil counts were significantly higher than in wild-type mice, but within the normal range for other mouse strains (e.g., FVB). Further analysis is necessary to determine whether this difference results in any impairment of the immune system. Unlike the Ruby rat, RAB38 is produced in Rab38cht/cht mice, which would be predicted for a point-mutation protein, but the steady state level of mutant RAB38 is much reduced. Recent in vitro work suggests that the chocolate allele produces functionally inactive RAB38.29 These results, along with data showing that Rab38cht/cht mice have normal bleeding times16 37 suggest that the Rab38cht/cht allele does not lead to the systemic abnormalities seen in HPS.
Our preliminary analysis of the RAB38 gene in a small number of patients with HPS or an HPS-like condition revealed only a single nucleotide change that does not result in amino acid substitution or clearly alter a splice site. In addition, this same nucleotide change was observed in patients with pigmentary glaucoma. A detailed systemic evaluation of the Rab38cht/cht mouse failed to reveal any abnormality beyond ocular and cutaneous pigmentation dilution. Specifically, the Rab38cht/cht mouse did not have the platelet dysfunction that is characteristic of HPS. Future studies of the functional significance of the Rab38cht allele and the human sequence change could be performed to elucidate the potential role of RAB38 in HPS. Alternatively, RAB38 could be involved in another form of syndromic albinism not covered in our patient sample.
Sequencing of the RAB38 gene in patients with OCA who did not have mutations in the known albinism genes did not reveal any sequence changes. Suzuki et al.38 likewise did not find any RAB38 mutations in their cohort of Japanese patients with albinism. We therefore conclude that RAB38 is not a major locus for human OCA. The fact remains, however, that the Rab38cht allele affects coat color; as such, it is still quite possible that RAB38—although not itself a major disease locus—modifies the phenotype in patients with pigment-related diseases.
| Acknowledgements |
|---|
| Footnotes |
|---|
Supported by the intramural program of the National Institutes of Health, the Howard Hughes Medical Institute, and National Eye Institute Grants EY01475 and EY11721. BPB is part of the Joint Physician-Scientist Development Program at the National Eye Institute and the National Human Genome Research Institute.
Submitted for publication December 11, 2006; revised April 30, 2007; accepted July 19, 2007.
Disclosure: B.P. Brooks, None; D.M. Larson, None; C.-C. Chan, None; S. Kjellstrom, None; R.S. Smith, None; M.A. Crawford, None; L. Lamoreux, None; M. Huizing, None; R. Hess, None; X. Jiao, None; J.F. Hejtmancik, None; A. Maminishkis, None; S.W.M. John, None; R. Bush, None; W.J. Pavan, None
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C.
1734 solely to indicate this fact.
Corresponding author: Brian P. Brooks, National Eye Institute, National Institutes of Health, Building 10, Room 10B16, Bethesda, MD 20892; brooksb{at}mail.nih.gov.
| References |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |